Allergy Therapeutics.
54 announcements.
54 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 21-11-2024 | AGY | Allergy Therapeutics | Notice of 2024 Annual General Meeting |
| 07:00 | 06-11-2024 | AGY | Allergy Therapeutics | Audited Preliminary Results 2024 |
| 07:00 | 21-10-2024 | AGY | Allergy Therapeutics | Commencement of Phase III Paediatric Trial |
| 07:00 | 16-10-2024 | AGY | Allergy Therapeutics | Update on funding |
| 07:00 | 01-10-2024 | AGY | Allergy Therapeutics | Update on funding and preliminary results |
| 07:00 | 17-09-2024 | AGY | Allergy Therapeutics | Progression of patient cohorts in PROTECT Trial |
| 07:00 | 27-08-2024 | AGY | Allergy Therapeutics | Update on funding |
| 07:00 | 22-07-2024 | AGY | Allergy Therapeutics | Appointment of Nominated Adviser and Sole Broker |
| 07:01 | 22-07-2024 | AGY | Allergy Therapeutics | Trading update for the year ended 30 June 2024 |
| 14:22 | 04-07-2024 | AGY | Allergy Therapeutics | Launch of new Company Long Term Incentive Plan |
| 07:00 | 27-06-2024 | AGY | Allergy Therapeutics | Appointment of Non-Executive Director |
| 07:00 | 10-06-2024 | AGY | Allergy Therapeutics | Progression of patient cohorts in PROTECT Trial |
| 07:00 | 03-06-2024 | AGY | Allergy Therapeutics | Successful meetings with Paul Ehrlich Institut |
| 07:00 | 07-05-2024 | AGY | Allergy Therapeutics | Further detail from G306 Phase III field trial |
| 07:00 | 03-04-2024 | AGY | Allergy Therapeutics | Director Resignation |
| 07:00 | 27-03-2024 | AGY | Allergy Therapeutics | Interim Results for six months ended 31 Dec 2023 |
| 07:00 | 27-03-2024 | AGY | Allergy Therapeutics | Update on funding |
| 08:59 | 12-03-2024 | AGY | Allergy Therapeutics | VLP Peanut PROTECT Trial Update |
| 07:00 | 11-03-2024 | AGY | Allergy Therapeutics | Appointment of Shaun Furlong to Board of Directors |
| 13:49 | 08-03-2024 | AGY | Allergy Therapeutics | Result of AGM |
| 07:00 | 14-02-2024 | AGY | Allergy Therapeutics | Half-Year Trading Update 2024 |
| 15:07 | 09-02-2024 | AGY | Allergy Therapeutics | Notice of 2023 Annual General Meeting |
| 07:30 | 30-01-2024 | AGY | Allergy Therapeutics | Restoration - Allergy Therapeutics plc |
| 07:00 | 30-01-2024 | AGY | Allergy Therapeutics | Publication of Annual Report and Accounts 2023 |
| 12:29 | 04-01-2024 | AGY | Allergy Therapeutics | Total Voting Rights |
| 07:30 | 02-01-2024 | AGY | Allergy Therapeutics | Suspension - Allergy Therapeutics plc |
| 12:01 | 27-12-2023 | AGY | Allergy Therapeutics | Amendment to existing Facility Agreement |
| 12:48 | 15-12-2023 | AGY | Allergy Therapeutics | Annual Report and Accounts Delayed |
| 16:54 | 13-12-2023 | AGY | Allergy Therapeutics | PDMR dealing and Total Voting Rights |
| 07:00 | 13-12-2023 | AGY | Allergy Therapeutics | G306 Phase III trial meets key endpoints |
| 07:00 | 11-12-2023 | AGY | Allergy Therapeutics | Update on funding |
| 07:00 | 01-12-2023 | AGY | Allergy Therapeutics | Total Voting Rights |
| 15:03 | 28-11-2023 | AGY | Allergy Therapeutics | Holding(s) in Company |
| 07:00 | 14-11-2023 | AGY | Allergy Therapeutics | G306 Grass Phase III trial meets primary endpoint |
| 13:22 | 10-11-2023 | AGY | Allergy Therapeutics | Director/PCA Dealing |
| 13:11 | 10-11-2023 | AGY | Allergy Therapeutics | Holding(s) in Company |
| 07:00 | 10-11-2023 | AGY | Allergy Therapeutics | Offer Closure |
| 10:48 | 09-11-2023 | AGY | Allergy Therapeutics | Exercise of Options and Total Voting Rights |
| 07:00 | 06-11-2023 | AGY | Allergy Therapeutics | Update on funding |
| 17:17 | 20-10-2023 | AGY | Allergy Therapeutics | Holding(s) in Company |
| 07:00 | 19-10-2023 | AGY | Allergy Therapeutics | Posting of Offer Document |
| 15:03 | 16-10-2023 | AGY | Allergy Therapeutics | Holding(s) in Company |
| 08:01 | 16-10-2023 | AGY | Allergy Therapeutics | Unconditional Mandatory Cash Offer |
| 07:00 | 13-10-2023 | AGY | Allergy Therapeutics | Result of Open Offer and Subscription |
| 12:04 | 27-09-2023 | AGY | Allergy Therapeutics | Publication of Open Offer Circular – Amendment |
| 07:01 | 27-09-2023 | AGY | Allergy Therapeutics | Publication of Open Offer Circular |
| 07:00 | 27-09-2023 | AGY | Allergy Therapeutics | Unaudited Preliminary Results 2023 |
| 07:00 | 26-09-2023 | AGY | Allergy Therapeutics | Phase I VLP Peanut PROTECT trial progress |
| 07:00 | 22-09-2023 | AGY | Allergy Therapeutics | Satisfaction of FDI clearance conditions |
| 07:00 | 10-08-2023 | AGY | Allergy Therapeutics | Trading update for the year ended 30 June 2023 |
| 13:12 | 10-07-2023 | AGY | Allergy Therapeutics | Appointment of Chief Financial Officer |
| 07:30 | 19-06-2023 | AGY | Allergy Therapeutics | Restoration - Allergy Therapeutics PLC |
| 07:01 | 19-06-2023 | AGY | Allergy Therapeutics | Interim Results and Lifting Suspension in Trading |
| 07:00 | 19-06-2023 | AGY | Allergy Therapeutics | Publication of Annual Report and Accounts 2022 |